Palliative Care for Leukemia
Trial Summary
What is the purpose of this trial?
The purpose of this study is to estimate the potential benefit of early and continued palliative care (PC) consultation on end of life issues.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Palliative Care, Supportive Care, End-of-Life Care, Symptom Management for leukemia?
Research shows that early integration of palliative care with standard treatment for leukemia can help manage painful symptoms and improve the quality of life for patients. It also highlights the benefits of palliative care in reducing unnecessary suffering and providing better support for both patients and caregivers.12345
Is palliative care safe for leukemia patients?
How is palliative care different from other treatments for leukemia?
Palliative care for leukemia focuses on relieving symptoms and improving quality of life rather than curing the disease. It is unique because it addresses not only physical symptoms but also emotional, social, and spiritual needs, providing support to both patients and their families throughout the illness.235910
Research Team
Karen Ballen, MD
Principal Investigator
University of Virginia
Eligibility Criteria
This trial is for adults aged 18 and older with a new or relapsed diagnosis of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML). Participants must be able to consent, follow the study plan, and not have Acute Promyelocytic Leukemia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention group will have regular visits with a palliative care specialist, twice a week in the hospital and about every other week out of the hospital. Monthly questionnaires will be completed.
Standard Care
Participants in the standard care group will see a palliative care specialist only if referred by their oncologist. Monthly questionnaires will be completed.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including emergency department visits, hospice services use, and quality of life measures.
Treatment Details
Interventions
- Palliative Care
Palliative Care is already approved in European Union, United States, Canada for the following indications:
- Symptom management for various conditions including cancer, neurological disorders, and end-of-life care
- Symptom management for various conditions including cancer, neurological disorders, and end-of-life care
- Symptom management for various conditions including cancer, neurological disorders, and end-of-life care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Virginia
Lead Sponsor